 |
|
|
| |
The Evolution of Integrase Strand Transfer Inhibitors: VH-184, a Third-Generation Inhibitor With an Enhanced Resistance Profile
|
| |
| |
IDSA 2026 October 21-24 Wash DC
Jerry L. Jeffrey,1 Jon Collins,1 Luise Rogg,2 Joseph Horton,3 Sherene Min,1 Cynthia Donovan,1 Turner Overton,1 Jorge Villacian4
1ViiV Healthcare, Durham, NC, USA; 2GSK, Durham, NC, USA; 3Parexel International, Durham, NC, USA; 4ViiV Healthcare, London, UK
|
| |
|
|
|
|
|
